Interleukin-1 family
This article's lead section may be too short to adequately summarize the key points. (December 2019) |
Interleukin-1 / 18 | |||||||||
---|---|---|---|---|---|---|---|---|---|
|
The Interleukin-1 family (IL-1 family) is a group of 11
Discovery
Discovery of these cytokines began with studies on the pathogenesis of
In 1985 two distinct, but distantly related complementary DNAs encoding proteins sharing human IL-1 activity were reported to be isolated from a macrophage cDNA library, thus defining two individual members of the IL-1 family –
The Interleukin-1 superfamily
IL-1 family is a group of 11 cytokines, which induces a complex network of proinflammatory cytokines and via expression of integrins on leukocytes and endothelial cells, regulates and initiates inflammatory responses.[5][6]
IL-1α and IL-1β are the most studied members because they were discovered first and because they possess strong proinflammatory effects. They have a natural antagonist IL-1Ra (IL-1 receptor antagonist). All three of them include a beta trefoil fold and bind IL-1 receptor (IL-1R) and activate signaling via MyD88 adaptor, which is described in the Signaling section of this page. IL-1Ra regulates IL-1α and IL-1β proinflammatory activity by competing with them for binding sites of the receptor.[5][7][8]
Nine IL-1 superfamily members occur in a single cluster on human chromosome two; sequence and chromosomal anatomy evidence suggest these formed through a series of gene duplications of a proto-IL-1β ligand.[9] In this way, IL-1β, IL-1α, IL-36α, IL-36β, IL-36γ, IL-36RA, IL-37, IL-38, and IL-1RA are very likely ancestral family members sharing a common lineage.[9] However, IL-18 and IL-33 are on different chromosomes and there is insufficient sequence or chromosomal anatomy evidence to suggest they share common ancestry with the other IL-1 superfamily members. IL-33 and IL-18 have been included into the IL-1 superfamily due to structural similarities, overlap in function and the receptors involved in their signalling.[9][10][11]
Synthesis
All of the members of IL-1 family, except
Nomenclature
The interleukin-1 superfamily has 11 members, which have similar
But according to new trends in
Name | Family name | Receptor | Coreceptor | Property | Chromosomal location |
---|---|---|---|---|---|
IL-1α |
IL-1F1 | IL-1RI | IL-1RAcP |
Proinflammatory |
2q14.1 |
IL-1β |
IL-1F2 | IL-1RI | IL-1RAcP | Proinflammatory | 2q14.1 |
IL-1Ra |
IL-1F3 | IL-1RI | NA | Antagonist for IL-1α, IL-1β | 2q14.1 |
IL-18 | IL-1F4 | IL-18Rα | IL-18Rβ | Proinflammatory | 11q23.1 |
IL-36Ra |
IL-1F5 | IL-1Rrp2 |
NA | Antagonist for IL-36α, IL-36β, IL-36γ | 2q14.1 |
IL-36α |
IL-1F6 | IL-1Rrp2 | IL-1RAcP |
Proinflammatory | 2q14.1 |
IL-37 |
IL-1F7 | Unknown | Unknown | Anti-inflammatory | 2q14.1 |
IL-36β |
IL-1F8 | IL-1Rrp2 | IL-1RAcP | Proinflammatory | 2q14.1 |
IL-36γ |
IL-1F9 | IL-1Rrp2 | IL-1RAcP | Proinflammatory | 2q14.1 |
IL-38 | IL-1F10 | IL-1Rrp2 | Unknown | Anti-inflammatory | 2q14.1 |
IL-33 | IL-1F11 | ST2 | IL-1RAcP | Th2 responses, proinflammatory |
9p24.1 |
Signaling
IL-1α or IL-1β bind first to the first
After the formation of receptor
Biological activity
IL-1 is intensely produced by tissue
IL-1α
IL-1α is synthesized as a precursor protein and it is constitutively stored in the
Inflammatory responses in the absence of infection (such as ischemia) are only dependent on IL-1α signaling via the Interleukin-1 receptor (IL-1R), rather than TLRs signaling. IL-1α also stimulates transcription and secretion of IL-1β from monocytes, so the initiator of immune responses is likely IL-1α precursor by induction of neutrophil infiltration. IL-1β seems to be an amplifier of inflammation by recruitment of macrophages in the context of sterile inflammation.[19][20][21]
IL-1β
IL-1β is synthesized as a precursor form protein only after stimulation, in contrast to IL-1α. Its expression is induced by
The synthesis of
IL-18 is also synthesized as a precursor which is cleaved by caspase-1.[18]
There are indications that IL-1, not least IL-1beta, is of importance for regulation energy metabolism. For instance, Rothwell and coworkers reported evidence that Leptin actions on food intake and body temperature are mediated by IL-1 at the level of the CNS (Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ: Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A 96:7047–7052, 1999). Moreover, lack of IL-1RI–mediated biological activity in IL-1 receptor knockout mice causes mature-onset obesity (Garcia M, Wernstedt I, Berndtsson A, Enge M, Bell M, Hultgren O, Horn M, Ahren B, Enerbäck S, Ohlsson C, Wallenius V, Jansson J-O. 2006. Mature onset obesity in interleukin-1 receptor I (IL-1RI) knockout mice. Diabetes, 55:1205-1213). A similar mature onset obesity has also been observed in IL-6 knockout mice (Wallenius V, Wallenius K, Ahrén B, Rudling M, Dickson SL, Ohlsson C, Jansson J-O. 2002 Interleukin-6 deficient mice develop mature-onset obesity. Nature Medicine 8:75-79). There are fewer reports on the effects on obesity by TNFalpha, the third classic proinflammatory cytokine, although Spiegelman and co-workers found that it has profound affects on glucose metabolism Gokhan S Hotamisligil, Narinder S Shargill, Bruce M. Spiegelman. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 01 Jan 1993: Vol. 259, Issue 5091, pp. 87–91DOI: 10.1126/science.7678183).
IL-1ra
IL-1ra is produced by monocytes, macrophages, neutrophils, fibroblasts, epithelial cells, Sertoli cells, microglia. IL-1ra is synthesized as a preprotein containing a classical 25 amino acid long signal sequence that allows secretion via the endoplasmic reticulum / Golgi apparatus. Mouse, rat and rabbit IL-1ra show 77, 75, and 78% sequence homology to human IL-1ra.[23] L-1ra shows approximately 30% homology to IL-1β at the protein level. Several forms of IL-1ra have been identified: the 17 kDa form, called sIL-1ra (s = soluble) or also IL-1ra1. It contains the classical signal sequence and is a secreted form of IL-1ra.[24] The other 2 forms, commonly referred to as icIL-1ra or IL-1ra2 and IL-1ra3, do not have a signal sequence, are not secreted, and remain strictly interacellular.[25] The soluble form is produced by hepatocytes and regulated by pro-inflammatory cytokines (IL1-β and a combination of IL1-β and IL-6) and other acute phase proteins. The intracellular form was found in fibroblasts, monocytes, neutrophils, keratinocytes and bronchial epithelial cells. IL-1ra is an important regulator of IL-1-induced expression and physiological responses elicited by IL-1. IL-1ra functions as a competitive inhibitor of IL-1 receptor in vivo and in vitro. It counteracts the effects of both IL-1α and IL-1β. Upon binding of IL-1ra, the IL-1 receptor does not transmit a signal to the cell. IL-1ra inhibits the release of both IL-1α and IL-1β, IL-2 secretion, cell surface IL-2 receptor expression. It blocks the stimulation of prostaglandin E2 synthesis in synovial cells and thymocyte proliferation. It also inhibits the release of leukotriene B4 from monocytes after stimulation with bacterial lipopolysaccharides. It blocks insulin release from isolated pancreatic cells.
Polymorphism of this gene is associated with an increased risk of osteoporotic fractures.[26] IL-1ra antagonist deficiency (DIRA) is a rare congenital disease. Affected children experience severe skin and bone inflammation, other organs such as the lungs may be affected.[27] IL-1ra is used in the treatment of rheumatoid arthritis. It is commercially produced as a recombinant form of IL-1ra and is called anakinra.
IL-18
IL-18 is known as a factor that induces the production of interferon gamma (IFN-γ).[28] It is a pro-inflammatory cytokine that shares similar biological effects to IL-12 and structural forms with the IL-1 family. Together with IL-12 it mediates cellular immunity. It binds to the IL-18Rα receptor. It is produced by monocytes, macrophages, osteoblasts, keratinocytes. It is synthesized as an inactive precursor that is proteolytically cleaved to the active 18 kDa form.[29] IL-18 stimulates IFN-γ production by T cells and NK cells. It acts either independently or synergizes with IL-12, which may lead to rapid activation of the monocyte / macrophage system.[30] The combination of this cytokine and IL-12 inhibits IL-4 dependent production of IgE and IgG1 and, in turn, promotes IgG2 production by B cells.[31] In addition to these physiological functions, IL-18 is involved in several serious inflammatory reactions. The amount of IL-18 receptor mRNA in the endometrium as well as the ratio of the amount of binding protein to interleukin is demonstrably increased in patients with endomyosis compared to individuals without endomyosis.[32] IL-18 is also amplified in Hashimoto's thyroiditis.[33] This interleukin has been shown to increase β amyloid production in neurons in Alzheimer's disease.[34]
IL-33
IL-33 is a dual function
IL-36α
IL-36α is expressed in spleen, lymph nodes, tonsils, bone marrow, B-cells. This member is unique in that it is additionally synthesized by T lymphocytes. It is most related to IL-37 and IL-36β.[38]
IL-36β
IL-36β is expressed in the tonsils, bone marrow, heart, placenta, lung, testes, intestine, monocytes and B-lymphocytes. It is most similar to IL-36α (IL-1F6). Two alternative transcripts encoding the same protein have been described.[39]
IL-36γ
IL-36γ is most produced by keratinocytes. It activates NF-κB via interleukin 1 receptor-like 2 (IL-1Rrp2) and is specifically inhibited by IL-36ra.[40] Its production increases after IL-1β and TNF-α stimulation, but not after IL-18 or IFN-γ stimulation. IL-36γ plays an important role in skin immunity and inflammation. Expression is increased during chronic contact hypersensitivity, herpes simplex virus infection [41] and psoriasis.[38]
IL-36ra
IL-36ra is highly expressed by keratinocytes, in psoriatic skin, placenta, uterus, brain, kidneys, monocytes, B-lymphocytes and dendritic cells. IL-36ra is 155 amino acids long and lacks a signal sequence. IL-36ra shares with IL-1ra 52% homology in the amino acid sequence. IL-36ra acts as a non-specific inhibitor of inflammation and innate immunity. It inhibits IL-36α induced NF-κB activation.[42]
IL-37
IL-37 is expressed in most tissues. It is the first member of the IL-1 family to form homodimers.[43] IL-37 non-specifically inhibits the inflammatory response and innate immunity. IL-1F7 has also been found in the nucleus where it can function as a nuclear factor. This cytokine may bind or may itself be a ligand of the IL-18 receptor (IL18R1 / IL-1Rrp). It binds to the interleukin 18 binding protein (IL18BP), forming a complex with the beta subunit of the IL-18 receptor (IL-1F4), thereby inhibiting its activity. 5 alternative transcripts encoding different IL-37 isoforms have been described.[44]
IL-38
IL-38 is expressed in the skin as well as in the tonsils. It regulates both innate and adaptive immunity. It binds to the soluble IL-1RI receptor. Two alternative transcripts encoding the same protein have been described.[45]
Cytokine-induced effector cytokine production
Similar functions have IL-1 to
IL-1 in disease and its clinical significance
IL-1 has a major role in neuroinflammation.
In terms of clinical use, because of its characterization as a
Nowadays, the blockade of IL-1 activity (especially
References
- PMID 27226996.
- S2CID 4240002.
- PMID 6083565.
- S2CID 10404996.
- ^ PMID 21304099.
- PMID 35003136.
- PMID 1738162.
- PMID 18650393.
- ^ PMID 29559685.
- PMID 16286016.
- PMID 8912881.
- PMID 11574262.
- PMID 20959797.
- PMID 22315422.
- ^ "Interleukins and interleukin receptors - HUGO Gene Nomenclature Committee". www.genenames.org. Archived from the original on 15 July 2017. Retrieved 3 May 2018.
- ^ S2CID 10388683.
- ^ 1. Simi A, Tsakiri N, Wang P, Rothwell NJ. Interleukin-1 and inflammatory neurodegeneration. Biochemical Society Transactions. 2007 Oct 1;35(5):1122–6.
- ^ PMID 22653747.
- ^ PMID 20133797.
- PMID 21930960.
- ^ PMID 22607177.
- PMID 22125454.
- PMID 7509813.
- PMID 7629520.
- PMID 10092080.
- PMID 10750554.
- PMID 19494218.
- S2CID 4323405.
- S2CID 30629282.
- PMID 8781267.
- PMID 9108085.
- PMID 19394601.
- PMID 20586818.
- PMID 22898493.
- ^ PMID 22307629.
- ^ PMID 19439663.
- ^ PMID 19666510.
- ^ PMID 10625660.
- ^ "IL36B interleukin 36 beta [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2019-08-31.
- PMID 11466363.
- PMID 10744718.
- ^ "Interleukin-1 Family: Ligands & Receptors". www.rndsystems.com. Retrieved 2019-08-31.
- PMID 12096920.
- ^ "IL37 interleukin 37 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2019-08-31.
- ^ "IL1F10 interleukin 1 family member 10 [Homo sapiens (human)] - Gene - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2019-08-31.
- PMID 19359475.
- PMID 16185251.
- ^ S2CID 39751767.
- S2CID 85495400.
- S2CID 667280.
- PMID 15309690.
- PMID 20116409.
- ^ "Anakinra". DrugBank Version 4.1. Archived from the original on 2014-01-29. Retrieved Jan 29, 2014.